Hansa Medical Ab

Lars H Bj&ouml;rck

Inga-Maria Frick

Anders Sjoholm

Tomas Borje Leandersson

Eugen Jan Karol Axcrona

Per &angst;kesson

The use of protein H, and fragments or derivatives thereof, as cytostatic agents, especially in the treatment of diseases involving undesired cell proliferation.

Use of protein H as cytostatic agent

A protein from serotype M1 has been characterized. This protein, called protein SIC, plays a role in pathogenicity and virulence. It inhibits hemolysis by interacting with the plasma proteins clusterin, and members of the cystatin protein super family such as hisitidine rich glycoprotein (HRG). The protein comprises at least one of the following partial amino acid sequences: (a) glu thr tyr thr ser arg asn phe; (b) asp trp ser gly asp asp trp pro glu asp asp trp; (c) arg ser gly val gly leu ser gln tyr gly trp ser; (d) trp ser ser asp lys lys asp glu thr glu asp lyr thr; (e) gly thr gly tyr glu lys arg asp asp trp gly gly pro gly; (f) lys arg asp asp trp arg gly pro gly his ile pro lys pro. The protein and antibodies specific for the protein can be used in analytical procedures for determining the present of virulent in a sample. The protein can also be used in vaccine compositions.

Growing community of inventors

Lund, Sweden

Lars H Björck

Growing community of inventors

Lund, Sweden

Lars H Bj&ouml;rck

Lars H Björck